Literature DB >> 17380435

Organ motion in image-guided radiotherapy: lessons from real-time tumor-tracking radiotherapy.

Hiroki Shirato1, Shinichi Shimizu, Kei Kitamura, Rikiya Onimaru.   

Abstract

External radiotherapy using imaging technology for patient setup is often called image-guided radiotherapy (IGRT). The most important problem to solve in IGRT is organ motion. Four-dimensional radiotherapy (4DRT), in which the accuracy of localization is improved - not only in space but also in time - in comparison to 3DRT, is required in IGRT. Real-time tumor-tracking radiotherapy (RTRT) has been shown to be feasible for performing 4DRT with the aid of a fiducial marker near the tumor. Lung, liver, prostate, spinal/paraspinal, gynecological, head and neck, esophagus, and pancreas tumors are now ready for dose escalation studies using RTRT.

Entities:  

Mesh：

Year:  2007        PMID： 17380435     DOI： 10.1007/s10147-006-0633-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN： 1341-9625            Impact factor:   3.402


  29 in total

1.  Three-dimensional movement of a liver tumor detected by high-speed magnetic resonance imaging.

Authors:  S Shimizu; H Shirato; B Xo; K Kagei; T Nishioka; S Hashimoto; K Tsuchiya; H Aoyama; K Miyasaka
Journal:  Radiother Oncol       Date:  1999-03       Impact factor: 6.280

2.  Prediction of respiratory tumour motion for real-time image-guided radiotherapy.

Authors:  Gregory C Sharp; Steve B Jiang; Shinichi Shimizu; Hiroki Shirato
Journal:  Phys Med Biol       Date:  2004-02-07       Impact factor: 3.609

3.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

4.  Speed and amplitude of lung tumor motion precisely detected in four-dimensional setup and in real-time tumor-tracking radiotherapy.

Authors:  Hiroki Shirato; Keishiro Suzuki; Gregory C Sharp; Katsuhisa Fujita; Rikiya Onimaru; Masaharu Fujino; Norio Kato; Yasuhiro Osaka; Rumiko Kinoshita; Hiroshi Taguchi; Shunsuke Onodera; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-03-15       Impact factor: 7.038

5.  Detection of lung tumor movement in real-time tumor-tracking radiotherapy.

Authors:  S Shimizu; H Shirato; S Ogura; H Akita-Dosaka; K Kitamura; T Nishioka; K Kagei; M Nishimura; K Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

6.  Uncertainty in treatment of head-and-neck tumors by use of intraoral mouthpiece and embedded fiducials.

Authors:  Masataka Oita; Keiichi Ohmori; Kenichi Obinata; Rumiko Kinoshita; Rikiya Onimaru; Kazuhiko Tsuchiya; Keishirou Suzuki; Takeshi Nishioka; Hiroyasu Ohsaka; Katsuhisa Fujita; Teppei Shimamura; Hiroki Shirato; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-04-01       Impact factor: 7.038

7.  Three-dimensional conformal setup (3D-CSU) of patients using the coordinate system provided by three internal fiducial markers and two orthogonal diagnostic X-ray systems in the treatment room.

Authors:  Hiroki Shirato; Masataka Oita; Katsuhisa Fujita; Shinichi Shimizu; Rikiya Onimaru; Shinji Uegaki; Yoshiharu Watanabe; Norio Kato; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-10-01       Impact factor: 7.038

8.  Reduction in acute morbidity using hypofractionated intensity-modulated radiation therapy assisted with a fluoroscopic real-time tumor-tracking system for prostate cancer: preliminary results of a phase I/II study.

Authors:  Kei Kitamura; Hiroki Shirato; Nobuo Shinohara; Toru Harabayashi; Rikiya Onimaru; Katsuhisa Fujita; Shinichi Shimizu; Katsuya Nonomura; Tomohiko Koyanagi; Kazuo Miyasaka
Journal:  Cancer J       Date:  2003 Jul-Aug       Impact factor: 3.360

9.  Precise and real-time measurement of 3D tumor motion in lung due to breathing and heartbeat, measured during radiotherapy.

Authors:  Yvette Seppenwoolde; Hiroki Shirato; Kei Kitamura; Shinichi Shimizu; Marcel van Herk; Joos V Lebesque; Kazuo Miyasaka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-07-15       Impact factor: 7.038

10.  Real-time tumor-tracking radiation therapy for lung carcinoma by the aid of insertion of a gold marker using bronchofiberscopy.

Authors:  Toshiyuki Harada; Hiroki Shirato; Shigeaki Ogura; Satoshi Oizumi; Koichi Yamazaki; Shinichi Shimizu; Rikiya Onimaru; Kazuo Miyasaka; Masaharu Nishimura; Hirotoshi Dosaka-Akita
Journal:  Cancer       Date:  2002-10-15       Impact factor: 6.860
View more
  12 in total

1.  Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: A review from NRG oncology.

Authors:  Edward D Brandner; Indrin J Chetty; Tawfik G Giaddui; Ying Xiao; M Saiful Huq
Journal:  Med Phys       Date:  2017-04-20       Impact factor: 4.071

Review 2.  Motion management in gastrointestinal cancers.

Authors:  Hassan Abbas; Bryan Chang; Zhe Jay Chen
Journal:  J Gastrointest Oncol       Date:  2014-06

Review 3.  Adaptive management of liver cancer radiotherapy.

Authors:  Kristy K Brock; Laura A Dawson
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

4.  Tracking target position variability using intraprostatic fiducial markers and electronic portal imaging in prostate cancer radiotherapy.

Authors:  F Munoz; C Fiandra; P Franco; A Guarneri; P Ciammella; P De Stefanis; N Rondi; F Moretto; S Badellino; C Iftode; R Ragona; U Ricardi
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

5.  Assessing four-dimensional radiotherapy planning and respiratory motion-induced dose difference based on biologically effective uniform dose.

Authors:  F-C Su; C Shi; P Mavroidis; V Goytia; R Crownover; P Rassiah-Szegedi; N Papanikolaou
Journal:  Technol Cancer Res Treat       Date:  2009-06

6.  Complications associated with the percutaneous insertion of fiducial markers in the thorax.

Authors:  Nikhil Bhagat; Nicholas Fidelman; Jeremy C Durack; Jeremy Collins; Roy L Gordon; Jeanne M LaBerge; Robert K Kerlan
Journal:  Cardiovasc Intervent Radiol       Date:  2010-07-27       Impact factor: 2.740

7.  Design and testing of a simulation framework for dosimetric motion studies integrating an anthropomorphic computational phantom into four-dimensional Monte Carlo.

Authors:  M Riboldi; G T Y Chen; G Baroni; H Paganetti; J Seco
Journal:  Technol Cancer Res Treat       Date:  2008-12

8.  Short-term outcomes of CyberKnife therapy for advanced high-risk tumors: A report of 160 cases.

Authors:  Yi-Shan Wang; Yuan-Yuan Wang; Peng Jiang; Jian-Jun Ma; Zhen Qu; Xi-Lin Wang; Jun-Ti Li; Xi-Feng Jia
Journal:  Exp Ther Med       Date:  2012-01-12       Impact factor: 2.447

9.  Stochastic rank correlation: a robust merit function for 2D/3D registration of image data obtained at different energies.

Authors:  Wolfgang Birkfellner; Markus Stock; Michael Figl; Christelle Gendrin; Johann Hummel; Shuo Dong; Joachim Kettenbach; Dietmar Georg; Helmar Bergmann
Journal:  Med Phys       Date:  2009-08       Impact factor: 4.071

10.  Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer.

Authors:  Jeong-Seon Ji; Chi-Wha Han; Jeong-Won Jang; Bo-In Lee; Byung-Wook Kim; Hwang Choi; Ji-Yoon Kim; Young-Nam Kang; Chul-Seung Kay; Ihl-Bohng Choi
Journal:  Radiat Oncol       Date:  2010-06-28       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.